Dr. Harish Kancharla

Education Qualifications

• DM (Medical Oncology), BRAIRCH, AIIMS, Delhi 2017-2020
• MD (Internal Medicine), PGIMER, Chandigarh 2013 - 2015
• MBBS, Gandhi Medical College, Hyderabad, Telangana, India 2006 - 2012

Experience

• Worked as Consultant Medical Oncology and Hemato Oncology at Cancer Clinics from July 2020 to May 2021
• September 2016 to July 2020- Senior Residency in Medical Oncology at BRAIRCH, All India Institute of Medical Sciences, Delhi, India
• January 2016 to September 2016- Senior Residency in Internal Medicine at PGIMER, Chandigarh, India
• Rotatary internship from Gandhi Medical College(NTRUHS), 2011-2012

Services offered

• Chemotherapy for solid and hematolymphoid malignancies
• Targeted therapy (precision oncology)
• Immunotherapy
• Hormonal therapy
• Bone marrow transplantation
• Hematological malignancies
• Paediatric oncology
• Solid tumors (breast cancer,lung cancer,stomach cancer,colon cancer,oral cancer, CNS tumors , kidney cancer, bladder cancer)
• PICC line insertion, bone marrow aspiration and biopsy, lumbar puncture
• Autologous stem cell transplant for hematological malignancies
• Familial and hereditary cancer treatment
• Cancer screening with genetic counselling
• Palliative and supportive care for advanced cancer patients

Special Interest and Expertise

• Preventive Oncology and hereditary cancers -screening and genetic counselling
• Genito-urinary cancers
• Head and neck cancers
• Gastrointestinal cancers
• Breast cancer
• Lung cancer
• Bone cancer and soft tissue sarcomas
• Paediatric malignancies
• Hematological malignancies and autologous stem cell transplantation
• Palliative and supportive care for advanced cancer

Professional Membership

• Telangana State Medical Council
• International Association for the Study of Lung Cancer (IASLC)
• European Society for Medical Oncology (ESMO)
• Indian Cooperative Oncology Network (ICON)

Research & Publications

• 2020 - Multiple Myeloma—Effect of Induction Therapy on Transplant Outcomes,Clinical Lymphoma Myeloma and Leukemia, Sept 2020 -Lalit Kumar, Naresh Gundu, Harish Kancharla, Ranjit Kumar Sahoo, Prabhat Singh Malik, Atul Sharma, Ritu Gupta, Omdutt Sharma
• 2020- Cytotoxic chemotherapy in advanced non–small cell lung cancer with poor performance status: Retrospective Analysis From Routine Clinical Practice–Current Problems in Cancer, January, 2020 Harish Kancharla, N Gundu, N Pathak, S Khurana , D Pushpam, S Kumar, Prabhat Singh Malik
• 2019 - Engraftment Syndrome: A Retrospective Analysis of the Experience at a Tertiary Care Institute Clinica. Hematology International Vol. 1(2),June 2019 — RajaPramanik,Harish Kancharla, SameerBakhshi, Atul Sharma, AjayGogia, Prabhat Mallik, Ranjit Kumar Sahoo, Lalit Kumar.
• 2019 -Non-small cell lung carcinoma patients with baseline brain imaging –A prospective observational study-Annals of Oncology —N. Gundu, P.S. Malik, S. Khurana, S. Patty, M. Yadav, D. Jain, Harish Kancharla
• 2017 - Comparison of the Four Validated Psoriatic Arthritis Screening Tools in Diagnosing Psoriatic Arthritis Patients with Psoriasis[COMPAQ Study] -BrJ Dermatol 2017 —. Mishra Sushant, Harish Kancharla, Dogra Sunil, Aman Sharma
• 2015 - Pancreatic pleural effusion due to ductal disruption upstream of a tight ductal stricture in patient with chronic calcific pancreatitis -Journal of Digestive Endoscopy, 2015 — Vishal Sharma, K.V. Raghavendra Prasada, Harish Kancharla, Ravi Sharma, Surinder S. Rana, Deepak. Bhasin
• Poster presentations
  • 2019- WCLC, 2019 in Barcelona ,Spain—Poster presentation- Cytotoxic chemotherapy in advanced non–small cell lung cancer with poor performance status: A retrospective analysis from routine clinical practice
  • 2017 - APLAR(Asia Pacific League of Associations for Rheumatology Congress), Dubai- Poster presentation Impact of Fibromyalgia on Health Associated Quality Of Life in Patients with Psoriatic Arthritis).

Awards and Achievements

• 2019 - 6th SPEAK National quiz conducted at Nagpur (Sun’s Platform for Education, Awareness & Knowledge)- First Prize
• 2019- Hematology Update National Quiz, 2019 ,Delhi- First Prize
• All India 1st Rank in DM/MCh entrance in Medical Oncology in April, 2017
• 2017- Update in Management of breast cancer National Quiz, conducted in AIIMS, Delhi- First Prize
• 2017- Best Abstract (APLAR CELLTRION) Award in 19th Asia Pacific League of Associations for Rheumatology Congress- APLAR 2017 (ABS091: Impact of Fibromyalgia on Health Associated Quality Of Life in Patients with Psoriatic Arthritis).

FAQ'S

1. 1. Why do patients frequently visit Dr. Harish Kancharla?
   

   Patients frequently visit Dr. Harish Kancharla for Chemotherapy for solid and hematolymphoid malignancies, Targeted therapy (precision oncology), Immunotherapy, Hormonal therapy, Bone marrow transplantation, Hematological malignancies. To see more reasons visit the doctor’s profile on Yashoda Hospitals.

2. 2. What is Dr. Harish Kancharla's education qualification?
   

   Dr. Harish Kancharla has the following qualifications – M.B.B.S, DM (Medical Oncology). You can book the doctor appointment through the doctor’s profile on Yashoda Hospitals

3. 3. What does Dr. Harish Kancharla specializes in?
   

   Dr. Harish Kancharla is specialized in Chemotherapy for solid and hematolymphoid malignancies, Targeted therapy (precision oncology), Immunotherapy, Hormonal therapy, Bone marrow transplantation, Hematological malignancies.

4. 4. Where does Dr. Harish Kancharla practice?
   

   Dr. Harish Kancharla practices at Yashoda Hospitals – Somajiguda.

5. 5. How can I book Dr. Harish Kancharla's appointment?
   

   You can book Dr. Harish Kancharla appointment online for Online video consultation and Opd consultation.

6. 6. How many years of experience does Dr. Harish Kancharla have?
   

   Dr. Harish Kancharla has 9 years of experience in Medical Oncology.